The Disaster ArchiveThe Disaster Archive
Back to Home
Pandemics & Epidemics

HIV/AIDS Crisis

A virus entered the world quietly, then spread through fear, prejudice, and denial—until science and activism forced medicine, governments, and culture to answer it.

1981 - PresentGlobal1981-present

Quick Facts

Period
1981 - Present
Region
Global
Key Figures
Françoise Barré-Sinoussi, Luc Montagnier, Michael Callen +2 more

Key Figures

The Story

This narrative combines documented history with dramatized scenes for storytelling purposes.

Timeline

CDC reports rare Pneumocystis pneumonia in five young men

**1981-06** — The CDC’s Morbidity and Mortality Weekly Report described five cases in Los Angeles, signaling a new and unexplained immune collapse in previously healthy adults. The report did not name the cause, but it marked the first official recognition that something unprecedented was occurring.

Kaposi’s sarcoma cases broaden the pattern

**1981-12** — Additional CDC reports linked rare cancers and immune deficiency to a growing cluster of cases in gay men in New York and California. The pattern demonstrated that the problem was not an isolated lung infection but a systemic disease process.

AIDS is named as a syndrome

**1982** — The CDC adopted the term acquired immune deficiency syndrome to describe the condition being observed across case reports. Naming the syndrome gave the epidemic administrative shape and allowed surveillance to expand.

The virus is isolated at the Institut Pasteur

**1983** — Françoise Barré-Sinoussi and Luc Montagnier’s team isolated the retrovirus later identified as HIV. This scientific breakthrough made diagnostic testing and future drug development possible.

The first HIV blood test enters use

**1985** — The availability of a screening test made it possible to protect the blood supply and identify infection before AIDS developed. It also revealed how far the virus had already spread through populations and institutions.

ACT UP forms in New York

**1987** — A new era of activist pressure began as people living with HIV and their allies demanded faster drug approval, better access, and an end to stigma. Their direct-action model changed the politics of the epidemic.

AZT is approved as the first antiretroviral drug

**1987** — The first HIV medication offered hope, though with major limits in toxicity and effectiveness. It marked the beginning of pharmacological treatment for a disease that had seemed untouchable.

Ryan White Act becomes law

**1990** — The United States created a major federal care program for people living with HIV/AIDS, acknowledging that access to treatment could not depend on local hostility or individual wealth. The law reflected changing public sentiment and activist pressure.

Combination antiretroviral therapy changes survival

**1996** — Protease inhibitor-based combinations dramatically reduced AIDS deaths in settings where the drugs were available and adhered to. The epidemic did not end, but the clinical meaning of HIV changed profoundly.

Global treatment access becomes a central policy issue

**2000** — International organizations increasingly treated HIV/AIDS as a development and equity crisis, not only a medical one. This shift helped drive large-scale funding and procurement efforts for antiretroviral therapy.

Nobel Prize recognizes the discovery of HIV

**2008** — Françoise Barré-Sinoussi and Luc Montagnier received the Nobel Prize in Physiology or Medicine for identifying the virus. The award symbolized how far the scientific response had come since the early years of panic and uncertainty.

UNAIDS updates the global toll

**2023** — UNAIDS estimated that 40.4 million people had died of AIDS-related illnesses since the beginning of the epidemic, while 39.9 million were living with HIV at the end of the year. The figures underscored both the scale of loss and the gains made possible by treatment and prevention.

Sources

Explore Related Archives

The disasters documented here connect to the broader record. Explore the context through our sister archives.